Corvus Pharmaceuticals (CRVS) Long-Term Investments (2022 - 2025)
Historic Long-Term Investments for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $11.5 million.
- Corvus Pharmaceuticals' Long-Term Investments fell 2407.98% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year decrease of 2407.98%. This contributed to the annual value of $12.5 million for FY2024, which is 2222.29% down from last year.
- Corvus Pharmaceuticals' Long-Term Investments amounted to $11.5 million in Q3 2025, which was down 2407.98% from $11.8 million recorded in Q2 2025.
- Over the past 5 years, Corvus Pharmaceuticals' Long-Term Investments peaked at $33.4 million during Q1 2022, and registered a low of $11.5 million during Q3 2025.
- Moreover, its 4-year median value for Long-Term Investments was $16.1 million (2023), whereas its average is $18.5 million.
- As far as peak fluctuations go, Corvus Pharmaceuticals' Long-Term Investments crashed by 4030.35% in 2023, and later tumbled by 1104.15% in 2024.
- Quarter analysis of 4 years shows Corvus Pharmaceuticals' Long-Term Investments stood at $21.9 million in 2022, then fell by 26.3% to $16.1 million in 2023, then dropped by 22.22% to $12.5 million in 2024, then fell by 8.05% to $11.5 million in 2025.
- Its last three reported values are $11.5 million in Q3 2025, $11.8 million for Q2 2025, and $12.1 million during Q1 2025.